<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A recent United Kingdom (UK) report found that breast and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> were more common in people with severe <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental illness</z:e> (SMI) and recommended targeted screening </plain></SENT>
<SENT sid="1" pm="."><plain>Epidemiological evidence is however inconsistent </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVES: To estimate relative incidence rates for colorectal, breast and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, and the overall incidence of the commonest other UK <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, in people with SMI compared with people without SMI </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: Cohort study in the UK using The Health Improvement Network (THIN) primary care database between 1990 and June 2008 </plain></SENT>
<SENT sid="4" pm="."><plain>Poisson regression was used to obtain adjusted incidence rate ratios (IRRs) for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, comparing two cohorts of people over 18; with and without a diagnosis of SMI </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We identified 20,632 people with SMI and 116,152 people without, with median follow up of over 6years </plain></SENT>
<SENT sid="6" pm="."><plain>No significant associations were observed between SMI and <z:e sem="disease" ids="C0006142,C0678222" disease_type="Neoplastic Process" abbrv="">cancers of the breast</z:e> (adjusted IRR 1.17; 95% confidence interval 0.95-1.45), colon (0.70; 0.46-1.05), rectum (1.05; 0.65-1.69) or lung (0.84; 0.65-1.10) </plain></SENT>
<SENT sid="7" pm="."><plain>The adjusted IRR for an aggregate <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> outcome in SMI was 0.95; 0.85-1.06 </plain></SENT>
<SENT sid="8" pm="."><plain>Results were similar for <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> and <z:hpo ids='HP_0007302'>bipolar disorder</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In a cohort analysis within a large UK primary care database, the incidence of colo-rectal, breast and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, and of <z:hpo ids='HP_0000001'>all</z:hpo> common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, did not differ significantly in people with SMI, including <z:hpo ids='HP_0100753'>schizophrenia</z:hpo>, compared with people without SMI </plain></SENT>
<SENT sid="10" pm="."><plain>Our results do not support enhanced screening procedures for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in people with SMI </plain></SENT>
</text></document>